Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

Fig. 1

Percentage of 34 countries with essential medicines for primary and secondary prevention of cardiovascular diseases. RAAS inhibitors: renin angiotensin aldosterone system inhibitors, from which angiotensin-converting enzyme (ACE inhibitors) and angiotensin receptor blockers (ARBs) are included. Selective beta-blocker here refers to β1-selective agents, including: metoprolol, bisoprolol, acebutolol, atenolol, betaxolol, celiprolol, esmolol, nebivolol. ADP- receptor blockers: adenosine diphosphate receptor inhibitors (especially P2Y12 receptor inhibitors) include medicines such as clopidogrel, prasugrel, ticagrelor

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us